Cargando…
Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs)
The interactions of derivatives of lumisterol (L3) and vitamin D3 (D3) with liver X receptors (LXRs) were investigated. Molecular docking using crystal structures of the ligand binding domains (LBDs) of LXRα and β revealed high docking scores for L3 and D3 hydroxymetabolites, similar to those of the...
Autores principales: | Slominski, Andrzej T., Kim, Tae-Kang, Qayyum, Shariq, Song, Yuwei, Janjetovic, Zorica, Oak, Allen S. W., Slominski, Radomir M., Raman, Chander, Stefan, Joanna, Mier-Aguilar, Carlos A., Atigadda, Venkatram, Crossman, David K., Golub, Andriy, Bilokin, Yaroslav, Tang, Edith K. Y., Chen, Jake Y., Tuckey, Robert C., Jetten, Anton M., Song, Yuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044163/ https://www.ncbi.nlm.nih.gov/pubmed/33850196 http://dx.doi.org/10.1038/s41598-021-87061-w |
Ejemplares similares
-
RF15 | PMON293 Metabolic activation of tachysterol to biologically active hydroxyderivatives that act on VDR, AhR, LXRs and PPARγ receptors
por: Slominski, Andrzej, et al.
Publicado: (2022) -
OR11-06 Biological Activity Of Lumisterol Hydroxymetabolites And Their Mechanism Of Action
por: Slominski, Andrzej T, et al.
Publicado: (2023) -
Novel CYP11A1-Derived Vitamin D and Lumisterol Biometabolites for the Management of COVID-19
por: Qayyum, Shariq, et al.
Publicado: (2022) -
Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols
por: Slominski, Andrzej T., et al.
Publicado: (2017) -
Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma
por: Slominski, Andrzej T., et al.
Publicado: (2023)